Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05355415 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adaptive Optics Imaging of Outer Retinal Diseases

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Aug 27, 2026 to Sep 30, 2028v4
  2. Primary and study completion dates: Apr 25, 2024 to Aug 27, 2026v3
  3. Re-verified, no change to tracked fieldsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina including photoreceptor, retinal pigment epithelium (RPE), basement membrane or choroidal pathologies) to develop new diagnostic methods, biomarkers, and clinical endpoints.
Trial Details
NCT Number NCT05355415
Lead Sponsor Food and Drug Administration (FDA)
Collaborators: National Eye Institute (NEI)
Conditions
(from sponsor)		 Retinal Degeneration, Age-Related Macular Degeneration, Retinitis Pigmentosa, Hydroxychloroquine Retinopathy, Usher Syndromes, Late-Onset Retinal Degeneration, Cone Dystrophy, Cone Rod Dystrophy +2 more
Related terms Cone Dystrophy, Cone-Rod Dystrophies, Late-Onset Retinal Degeneration, Macular Degeneration, Retinal Degeneration, Retinitis Pigmentosa, Usher Syndromes
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov